WO2002038097A1 - Hydrogel wound dressings - Google Patents

Hydrogel wound dressings Download PDF

Info

Publication number
WO2002038097A1
WO2002038097A1 PCT/GB2001/004983 GB0104983W WO0238097A1 WO 2002038097 A1 WO2002038097 A1 WO 2002038097A1 GB 0104983 W GB0104983 W GB 0104983W WO 0238097 A1 WO0238097 A1 WO 0238097A1
Authority
WO
WIPO (PCT)
Prior art keywords
wound dressing
dressing according
wound
top sheet
preceding
Prior art date
Application number
PCT/GB2001/004983
Other languages
French (fr)
Inventor
Deborah Addison
Derek Walter Silcock
Original Assignee
Johnson & Johnson Medical Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GBGB0027674.1A priority Critical patent/GB0027674D0/en
Priority to GB0027674.1 priority
Application filed by Johnson & Johnson Medical Limited filed Critical Johnson & Johnson Medical Limited
Publication of WO2002038097A1 publication Critical patent/WO2002038097A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive plasters or dressings
    • A61F13/0203Adhesive plasters or dressings having a fluid handling member
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/51Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers
    • A61F13/511Topsheet, i.e. the permeable cover or layer facing the skin
    • A61F13/51121Topsheet, i.e. the permeable cover or layer facing the skin characterised by the material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/51Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers
    • A61F13/511Topsheet, i.e. the permeable cover or layer facing the skin
    • A61F13/512Topsheet, i.e. the permeable cover or layer facing the skin characterised by its apertures, e.g. perforations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/51Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers
    • A61F13/511Topsheet, i.e. the permeable cover or layer facing the skin
    • A61F13/513Topsheet, i.e. the permeable cover or layer facing the skin characterised by its function or properties, e.g. stretchability, breathability, rewet, visual effect; having areas of different permeability
    • A61F13/51305Topsheet, i.e. the permeable cover or layer facing the skin characterised by its function or properties, e.g. stretchability, breathability, rewet, visual effect; having areas of different permeability having areas of different permeability
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/551Packaging before or after use

Abstract

The invention provides a wound dressing comprising: a liquid-permeable top sheet having a wound facing surface and a back surface, said top sheet being adapted to block or restrict passage of liquid from the back surface to the wound facing surface; and an insoluble hydrogel layer on the wound facing surface of the top sheet.

Description

HYDROGEL WOUND DRESSINGS

The present invention relates to wound dressings incorporating an absorbent structure and a hydrogel layer for the maintenance of a suitable moisture level at the surface of wounds.

It is known that the maintenance of a moist wound environment promotes the healing of wounds, especially burns and chronic wounds such as ulcers. However, it is also desirable to avoid excessive moisture or pooling of wound exudate on the wound, since liquid exudate causes maceration of skin adjacent to the wound and other difficulties. Furthermore, liquid exudate can leak from the wound site and contaminate clothes or bedding.

In practice, it is difficult to maintain the desired moisture level at the wound site because the rate of wound fluid production varies from wound to wound, and over time for any single wound. This can necessitate frequent dressing changes and a range of dressing types to treat different wounds.

It is an object of the present invention to provide structures for use as or in improved multilayer dressings for the treatment of a wide range of wounds.

The present invention provides a wound dressing comprising: a liquid- permeable top sheet having a wound facing surface and a back surface, said top sheet being adapted to block or restrict passage of liquid from the back surface to the wound facing surface; and a hydrogel layer on the wound facing surface of the top sheet.

Preferably, the dressing further comprises a backing layer over the back face of the top sheet. The backing layer supports the top sheet and an intermediate absorbent layer (where present) and preferably provides a barrier to passage of microorganisms through the dressing. The backing layer may extend beyond at least one edge of the absorbent layer to provide an adhesive-coated margin adjacent to the said edge for adhering the dressing to a surface, such as to the skin of a patient adjacent to the wound being treated. An adhesive-coated margin may extend around all sides of the absorbent layer, so that the dressing is a so-called island dressing. However, it is not necessary for there to be any adhesive-coated margin.

Preferably, the backing layer is substantially liquid-impermeable. The backing sheet is preferably semipermeable. That is to say, the backing sheet is preferably permeable to water vapour, but not permeable to liquid water or wound exudate. Preferably, the backing sheet is also microorganism-impermeable. Suitable continuous conformable backing sheets will preferably have a moisture vapor transmission rate (MVTR) of the backing sheet alone of 300 to 5000 g/m2/24hrs, preferably 500 to 2000 g/m2/24hrs at 37.5 °C at 100% to 10% relative humidity difference. The backing sheet thickness is preferably in the range of 10 to 1000 micrometers, more preferably 100 to 500 micrometers.

The MVTR of the dressing according to the present invention as a whole is lower than that of the backing sheet alone, because the top sheet partially obstructs moisture transfer through the dressing. Preferably, the MVTR of the dressing (measured across the island portion of the dressing) is from 20% to 80% of the MVTR of the backing sheet alone, more preferably from 20% to 60% thereof, and most preferably about 40% thereof. It has been found that such moisture vapor transmission rates allow the wound under the dressing to heal under moist conditions without causing the skin surrounding the wound to macerate.

Suitable polymers for forming the backing sheet include polyurethanes and poly alkoxyalkyl acrylates and methacrylates such as those disclosed in GB-A- 1280631. Preferably, the backing sheet comprises a continuous layer of a high density blocked polyurethane foam that is predominantly closed-cell. A suitable backing sheet material is the polyurethane film available under the Registered Trade Mark ESTANE 5714F. The adhesive (where present) layer should be moisture vapor transmitting and/or patterned to allow passage of water vapor therethrough. The adhesive layer is preferably a continuous moisture vapor transmitting, pressure-sensitive adhesive layer of the type conventionally used for island-type wound dressings, for example, a pressure sensitive adhesive based on acrylate ester copolymers, polyvinyl ethyl ether and polyurethane as described for example in GB-A-1280631. The basis weight of the adhesive layer is preferably 20 to 250 g/m2, and more preferably 50 to 150 g/m2. Polyurethane-based pressure sensitive adhesives are preferred.

Preferably, the adhesive layer extends outwardly from the absorbent layer and the envelope to form an adhesive-coated margin on the backing sheet around the adhesive layer as in a conventional island dressing.

The area of the optional absorbent layer is typically in the range of from

1 cm2 to 200cm2, more preferably from 4cm2 to 100cm2.

The optional absorbent layer may be any of the layers conventionally used for absorbing wound fluids, serum or blood in the wound healing art, including gauzes, nonwoven fabrics, superabsorbents, hydrogels and mixtures thereof. Preferably, the absorbent layer comprises a layer of absorbent foam, such as an open celled hydrophilic polyurethane foam prepared in accordance with EP-A- 0541391 , the entire content of which is expressly incorporated herein by reference. In other embodiments, the absorbent layer may be a nonwoven fibrous web, for example a carded web of viscose staple fibers. The basis weight of the absorbent layer may be in the range of 50-500g/m2, such as 100-400g/m2. The uncompressed thickness of the absorbent layer may be in the range of from 0.5mm to 10mm, such as 1 mm to 4mm. The free (uncompressed) liquid absorbency measured for physiological saline may be in the range of 5 to 30 g/g at 25°C.

The optional absorbent layer may additionally comprise one or more active therapeutic or antimicrobial agents. Suitable therapeutic agents include growth factors, analgesics, local anaesthetics and steroids. Suitable antimicrobial agents include antiseptics such as silver compounds (e.g. silver sulfadiazine) and chlorhexidine, and antibiotics. The therapeutic or antimicrobial agents are usually added in an amount of from 0.01% to 5% by weight, based on the dry weight of the absorbent layer. Provision of the antimicrobial in the absorbent layer may be preferable for two reasons (1) Simple manufacturing route, and (2) Having the antimicrobial away from the wound would prevent unnecessary exposure to the antimicrobial when it may not be needed, e.g. drier wounds. In the presence of higher exudate, higher levels of the antimicrobial will be released as the absorbent layer becomes wet. Whilst the directional top sheet should restrict the flow of exudate back to the wound (to some extent through surface tension of the liquid), the antimicrobial should go against the concentration gradient and pass back through the perforated sheet and into the wound. It is know that antimicrobial components such as silver ions can be transported through relatively low levels of moisture.

The top sheet of the wound dressing according to the invention is liquid permeable, but acts to block or restrict the flow of liquid from the back surface to the wound site. That is to say, the top sheet allows fluid to pass through the top sheet from the wound site, but blocks or restricts flow of the fluid back through the top sheet onto the wound (also known as wet-back). Such non-wetting or top sheets may for example be made from porous non-woven fabrics comprising a layer of hydrophobic fibers, or having a hydrophobic finish applied to at least the outer surface thereof. Preferably, the top sheet has greater liquid permeability to the flow of liquid away from the wound facing surface than to the flow of liquid towards the wound facing surface.

Preferably, the top sheet is formed from a substantially liquid-impermeable sheet material provided with tapered capillaries, each capillary having a base substantially in the plane of the wound facing surface of the top sheet and an apical opening remote from the wound facing surface of the top sheet and preferably in contact with an absorbent layer. The conical capillaries provide rapid one-way wicking of fluid from the front of the top sheet, with minimal wetback. Top sheets of this type are described in GB-A-1526778.

The top sheet film may be formed from a thermoplastic film-forming polymer. Preferably, the polymer is conformable but not substantially elastomeric. Suitable polymers include, but are not limited to, polyethylene, polypropylene, polyester, polyamides such as nylons, fluoropolymers such as polyvinylidene fluoride (PVDF) or polytetrafluoroethylene (PTFE), and mixtures thereof. The top sheet is preferably a polyolefin film. Preferably, the film has a thickness by weight (ASTM E252-84) of from 10 to 200 micrometers, more preferably from 25 to 100 micrometers.

Preferably, the capillaries are substantially in the form of truncated cones. Preferably, the capillaries have a base opening dimension (the maximum opening dimension in the plane of the top sheet) of from 0.1 mm to 3 mm, and an apical opening dimension (remote from the plane of the top sheet) of from 0.05 to 2 mm. More preferably, the capillaries have a base opening dimension as herein defined of from 0.3 mm to 1 mm, and an apical opening dimension of from 0.1 to 0.5 mm.

Preferably, the capillaries have an average angle of taper (measured from the perpendicular to the plane of the top sheet) of from 10 to 60 degrees. Preferably, the embossed thickness of the top sheet (by ASTM D374-79) is from 0.2 to 2 mm, more preferably from 0.4 to 1 mm.

Top sheets of this type may be manufactured, for example, by embossing or vacuum perforation of a liquid-impermeable thermoplastic film. Preferably, the density of the capillaries is from 10 to 400 per cm2, more preferably from 50 to 200 per cm2. Preferably, the open area of the top sheet is from 5 to 50% of the total area, more preferably from 10 to 25% of the total area.

It has now been found, surprisingly, that the application of a hydrogel layer to the top surface of such a top sheet enables a moist wound environment to be maintained for prolonged periods, over a wide range of wound exudation rates. The top sheet continues to wick away wound fluid to prevent excessive moisture in the wound, but this does not result in removal of the hydrogel or blocking of the top sheet by the hydrogel. When the rate of wound exudate production falls, the hydrogel absorbs moisture vapor from the absorbent layer and preserves a moist wound contacting surface. The hydrogel does not give rise to substantially increased wet-back through the top sheet.

Preferably, the hydrogel layer has a dry basis weight of from 10 to 200g/m2, more preferably from 10 to 100g/m2, and most preferably from 10 to 50g/m2.

The term "hydrogel layer" refers generally to layers that interact with the wound surface under physiological conditions to maintain an elevated moisture level at the wound surface. Preferably, the hydrogel layer forms a gel with water under physiological conditions of temperature and pH. Such hydrogel layers can be formed by the inclusion of medically acceptable macromolecular materials that preferably have the ability to swell and absorb fluid while maintaining a strong integral structure. The hydrogel material is substantially insoluble in water under physiological conditions, whereby the hydrogel is not washed away by the wound fluid. The hydrogel may be a biopolymer, and/or it may be bioabsorbable. That is to say, it may undergo gradual resorption in vivo.

Exemplary insoluble gels include certain cross-linked polyacrylate gels, calcium alginate gels, cross-linked hyaluronate gels, wherein the hydrogel layer comprises a hydrogel material selected from gels formed from vinyl alcohols, vinyl esters, vinyl ethers and carboxy vinyl monomers, meth(acrylic) acid, acrylamide, N-vinyl pyrrolidone, acylamidopropane sulphonic acid, PLURONIC (Registered Trade Mark) (block polyethylene glycol, block polypropylene glycol) polystyrene-, maleic acid, NN-dimethylacrylamide diacetone acrylamide, acryloyl morpholine, and mixtures thereof. Preferably, the gel adheres strongly to the surface of the top sheet material to resist washing off by wound fluid. In certain embodiments the gel may be chemically bonded to the surface of the top sheet. Preferably, the hydrogel layer comprises a hydrogel material selected from polyurethane gels, biopolymer gels, carboxymethyl cellulose gels, hydroxyethyl cellulose gels, hydroxy propyl methyl cellulose, modified acrylamide and mixtures thereof. Suitable biopolymer gels include alginates, pectins, galactomannans, chitosan, gelatin, hyaluronates and mixtures thereof. Some of these biopolymer materials also promote wound healing.

Preferably, the gels are cross-linked, and the cross-linking may be either covalent or ionic.

Preferably, the hydrogel material further comprises from 5 to 50% by weight on a dry weight basis of one or more humectants such as glycerol.

Preferably, the hydrogel layer comprises a hydrogel material of the kind described in WOOO/07638, the entire contents of which is incorporated herein by reference.

Alternatively or additionally to the gel-forming macromolecules, the hydrogel layer may comprise one or more emollients. Emollients are used to smooth the surface of skin and to increase the degree of hydration. They act either by occluding water loss from the outer layer of the skin, or by improving water binding to the skin. Emollients are particularly useful in the treatment of atopic eczemas and ichthyoses. Preferred emollients include White Soft Paraffin, Yellow Soft Paraffin, Liquid paraffin, Urea Creams, Lanolin, Sodium Pyrrolidone Carboxylate (PCA Na), Evening primrose extract (gamma linolenic acid), Soya Oil, Tea Tree Oil, Coconut Oil, Almond Oil, Camomile Extract, Cod Liver Oil, Peanut Oil, Emu Oil, Aloe Vera, Sunflower oil, Avocado Oil, Jojoba Oil, Cocoamide, and mixtures thereof.

The hydrogel layer may additionally comprise one or more active therapeutic or antimicrobial agents. Suitable therapeutic agents include growth factors, analgesics, local anaesthetics and steroids. Suitable antimicrobial agents include antiseptics such as silver compounds (e.g. silver sulfadiazine) and chlorhexidine, and antibiotics. The therapeutic or antimicrobial agents are usually added in an amount of from 0.01 % to 5% by weight, based on the dry weight of the hydrogel layer.

The hydrogel layer may be continuous or discontinuous, but in any case is preferably apertured in register with the capillaries in the top sheet so as not to obstruct passage of fluid into the capillaries even when the hydrogel is fully swelled. In other words, there is preferably substantially no hydrogel initially present in or covering the capillaries of the top sheet. The hydrogel layer may be applied by spraying or, preferably, by a printing or transfer process.

Preferably, the multilayer wound dressing according to the invention further comprises one or more protective cover sheets over the hydrogel layer and any exposed adhesive. For example, these may comprise one or more release-coated paper cover sheets. Preferably, the dressing is sterile and packaged in a microorganism-impermeable container.

The present invention further provides the use of a multilayer wound dressing according to the present invention for the preparation of a dressing for application to a wound.

In a further aspect, the present invention provides a method of treatment of a wound comprising the step of applying a dressing in accordance with the present invention to the surface of the wound with the hydrogel contacting the wound.

An embodiment of the present invention will now be described further, by way of example, with reference to the accompanying drawings, in which:

Figure 1 shows a perspective view of the lower (wound contacting) surface of a wound dressing according to the invention; and

Figure 2 shows a partial transverse cross section (not to scale) through the island region of the dressing of Figure 1.

Referring to Figure 1 , the wound dressing is an island-type self-adhesive wound dressing comprising a backing layer 1 of microporous liquid-impermeable polyurethane foam, such as ESTANE 5714F (Registered Trade Mark). The backing layer is permeable to water vapor, but impermeable to wound exudate and microorganisms.

The backing layer 1 is coated with a substantially continuous layer 2 of pressure-sensitive polyurethane adhesive.

The absorbent layer 3 is a layer of hydrophilic polyurethane foam prepared as described in EP-A-0541391 and having a basis weight of about 350g/m2 and a thickness of about 1.5 mm.

The top sheet 4 extends over the absorbent layer 3 and is wrapped partially around the absorbent layer 3 and the edges 5 of the top sheet are adhered to the backing layer 1 behind the absorbent layer 3 by the adhesive 2. This can be seen more clearly in Figure 2. The top sheet is a polyethylene film that has been perforated with about 90 perforations per cm2, each perforation having a substantially conical shape as hereinbefore described, a maximum hole diameter of about 0.5 mm, an open area of 16% of the total area of the front face, a thickness by weight of about 43 micrometers and an embossed thickness of about 0.5 mm. Such top sheets are available from Tredegar Film Products, Richmond, Virginia under the Registered Trade Mark VISPORE. Referring to Figure 2, the top sheet 4 presents a smooth, perforated top surface to the wound This surface is coated with a layer of hydrogel 6 applied by spraying that is apertured in register with the capillaries in the top sheet to allow passage of fluid into the capillaries even when the hydrogel is fully swelled. The hydrogel 6 has a dry basis weight of 30g/m2 and consists of bovine gelatin cross- linked with glutaraldehyde or formaldehyde.

The wound facing surface of the dressing shown in Figure 1 is protected by two silicone-coated release papers 8,9, packed in a microorganism-impermeable pouch, and sterilised using gamma radiation.

In use, the dressing is removed from the package, the release papers are removed, and the dressing is adhered to the skin around the wound with the top sheet and hydrogel in contact with the wound to provide a sterile and absorbent dressing. The hydrogel and top sheet interact in hitherto unexpected ways to provide a moist but not wet wound environment for a wide range of wounds over an extended period.

The above embodiment has been described by way of example only. Many other embodiments falling within the scope of the accompanying claims will be apparent to the skilled reader.

Claims

1. A wound dressing comprising: a liquid-permeable top sheet having a wound facing surface and a back surface, said top sheet being adapted to block or restrict passage of liquid from the back surface to the wound facing surface; and a hydrogel layer on the wound facing surface of the top sheet.
2. A wound dressing according to claim 1 , further comprising an absorbent layer in contact with the back surface of the top sheet.
3. A wound dressing according to any preceding claim, wherein the absorbent layer comprises a layer of hydrophilic foam, a superabsorbent, or a combination thereof.
4. A wound dressing according to claim 2 or 3, wherein the absorbent layer further comprises a medicament.
5. A wound dressing according to any preceding claim, wherein the dressing further comprises a substantially liquid-impermeable backing layer over the absorbent layer.
6. A wound dressing according to claim 5, further comprising a layer of adhesive on the surface of the backing layer facing the top sheet.
7. A wound dressing according to claim 6, wherein the backing layer extends beyond at least one edge of the absorbent layer to provide an adhesive-coated margin adjacent to said edge for adhering the dressing to a surface.
8. A wound dressing according to any preceding claim, wherein the top sheet comprises a porous, substantially hydrophobic, non-woven fabric.
9. A wound dressing according to any preceding claim, wherein the top sheet is formed from a liquid-impermeable sheet material provided with tapered capillaries, each capillary having a base substantially in the wound facing surface of the top sheet and an apical opening remote from the plane of the top sheet and in contact with the absorbent layer.
10. A wound dressing according to claim 9, wherein the capillaries are substantially in the form of truncated cones.
11. A wound dressing according to claim 9 or 10, wherein the capillaries have a base opening dimension as herein defined of from 0.15 mm to 6 mm, and an apical opening dimension of from 0.1 to 2.5 mm.
12. A wound dressing according to claim 11 , wherein the capillaries have a base opening dimension as herein defined of from 0.5 mm to 1.5 mm, and an apical opening dimension of from 0.1 to 0.5 mm.
13. A wound dressing according to any of claims 9 to 12, wherein the capillaries have an average angle of taper as herein defined of from 10 to 60 degrees.
14. A wound dressing according to any preceding claim, wherein the hydrogel layer has a dry basis weight of from 10 to 200g/m2.
15. A wound dressing according to any preceding claim, wherein the hydrogel layer comprises a hydrogel material selected from polyurethane gels, biopolymer gels, carboxymethyl cellulose gels, hydroxyethyl cellulose gels hydroxypropyl methyl cellulose, modified acrylamides and mixtures thereof.
16. A wound dressing according to any preceding claim, wherein the hydrogel layer comprises a hydrogel material selected from gels formed from vinyl alcohols, vinyl esters, vinyl ethers and carboxy vinyl monomers, meth(acrylic) acid, acrylamide, N-vinyl pyrrolidone, acylamidopropane sulphonic acid, pluronic (block polyethylene glycol, block polypropylene glycol)polystyrene maleic acid, NN- dimethylacrylamide, diacetone acrylamide or acryloyl morpholine.
17. A wound dressing according to any preceding claim, wherein the hydrogel layer comprises an emollient.
18. A wound dressing according to claim 17, wherein the emollient is selected from the group consisting of white soft paraffin, yellow soft paraffin, liquid paraffin, urea creams, lanolin, sodium pyrrolidone carboxylate, evening primrose extract (gamma linolenic acid), soya oil, tea tree oil, coconut oil, almond oil, camomile extract, cod liver oil, peanut oil, emu oil, aloe vera, sunflower oil, avocado oil, jojoba oil, cocoamide, and mixtures thereof.
19. A wound dressing according to any preceding claim, wherein the hydrogel layer comprises an active therapeutic agent or an antimicrobial agent.
20. A wound dressing according to claim 19, wherein the hydrogel layer comprises a silver compound.
21. A wound dressing according to any preceding claim, wherein the hydrogel layer is apertured in register with apertures in the top sheet.
22. A wound dressing according to any preceding claim, further comprising one or more protective cover sheets over the hydrogel layer.
23. A wound dressing according to any preceding claim, wherein the dressing is sterile and packaged in a microorganism-impermeable container.
24. Use of a wound dressing according to any preceding claim for the preparation of a dressing for application to a wound.
PCT/GB2001/004983 2000-11-13 2001-11-12 Hydrogel wound dressings WO2002038097A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0027674.1A GB0027674D0 (en) 2000-11-13 2000-11-13 Hydrogel wound dressings
GB0027674.1 2000-11-13

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002540687A JP2004520096A (en) 2000-11-13 2001-11-12 Hydrogel wound dressing
AU1255202A AU1255202A (en) 2000-11-13 2001-11-12 Hydrogel wound dressings
EP01980764A EP1333788A1 (en) 2000-11-13 2001-11-12 Hydrogel wound dressings

Publications (1)

Publication Number Publication Date
WO2002038097A1 true WO2002038097A1 (en) 2002-05-16

Family

ID=9903069

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2001/004983 WO2002038097A1 (en) 2000-11-13 2001-11-12 Hydrogel wound dressings

Country Status (6)

Country Link
EP (1) EP1333788A1 (en)
JP (1) JP2004520096A (en)
AU (1) AU1255202A (en)
GB (1) GB0027674D0 (en)
TW (1) TW590763B (en)
WO (1) WO2002038097A1 (en)

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003011352A1 (en) * 2001-07-26 2003-02-13 Johson & Johson Medical Limited Apertured sheet materials consisting of a hydrogel composition
WO2003045294A1 (en) * 2001-11-23 2003-06-05 Johnson & Johnson Medical Limited Absorbent wound dressing containing a hydrogel layer
WO2004028423A1 (en) * 2002-09-27 2004-04-08 Johnson & Johnson Medical Limited Wound treatment device
WO2004052414A1 (en) * 2002-12-12 2004-06-24 Johnson & Johnson Medical Limited Absorbent multilayer hydrogel wound dressings
WO2004112851A1 (en) * 2003-06-23 2004-12-29 Johnson & Johnson Medical Limited Hydrogel compositions comprising enzymes
WO2005072669A1 (en) * 2004-01-30 2005-08-11 Hisamitsu Pharmaceutical Co., Inc. Cover material and plaster with cover material
EP1649873A2 (en) * 2004-10-22 2006-04-26 First Water Limited Absorbent materials and articles
JP2007517557A (en) * 2004-01-09 2007-07-05 バイオ−ゲイト アーゲーBio−Gate Ag Wound dressing
WO2008055586A1 (en) * 2006-11-07 2008-05-15 Paul Hartmann Ag Multi-layer, absorbing wound dressing having a hydrophilic wound contact layer
DE102008031183A1 (en) 2008-07-03 2010-01-07 Paul Hartmann Ag wound dressing
DE102008031182A1 (en) 2008-07-03 2010-01-07 Paul Hartmann Ag Wound dressing with hydrogel matrix
US7732655B2 (en) 2001-12-06 2010-06-08 Systagenix Wound Management (Us), Inc. Controlled release therapeutic wound dressings
US7750201B2 (en) * 2006-04-11 2010-07-06 Tyco Healthcare Group Lp Wound dressings with anti-microbial and chelating agents
US7799965B2 (en) * 2006-04-11 2010-09-21 Tyco Healthcare Group Lp Wound dressings with anti-microbial and zinc-containing agents
WO2011082772A1 (en) 2009-12-24 2011-07-14 Paul Hartmann Ag Hydrogel matrix having increased absorption capacity for liquids
WO2011095194A1 (en) 2009-12-24 2011-08-11 Paul Hartmann Ag Hydrogel matrix having improved adhesive properties
US8211078B2 (en) 2005-02-17 2012-07-03 The Procter And Gamble Company Sanitary napkins capable of taking complex three-dimensional shape in use
US8263116B2 (en) 2006-03-10 2012-09-11 Cellulose Concepts, Llc Methods for producing silver-bonded antimicrobial moist wound dressings and moist wound dressings produced by the methods
WO2014130567A1 (en) * 2013-02-20 2014-08-28 Carefusion 2200, Inc. Antimicrobial hydrogel polymers
US20140255476A1 (en) * 2011-08-19 2014-09-11 University Of Washington Through Its Center For Commercialization Compositions, devices, and methods for treating infections
US9579238B2 (en) 2005-02-17 2017-02-28 The Procter & Gamble Company Sanitary napkins capable of taking complex three-dimensional shape in use
EP3107619A4 (en) * 2014-02-18 2018-05-02 University Of South Australia Plasma hydrogel therapy

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4783429B2 (en) * 2006-07-06 2011-09-28 株式会社瑞光 Wound dressing
CA2600249C (en) * 2006-09-12 2014-05-20 Tyco Healthcare Group Lp Thin film dressing
TWI335820B (en) 2007-08-08 2011-01-11 Medical & Pharm Ind Tech & Dev Compound dressing

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929135A (en) * 1974-12-20 1975-12-30 Procter & Gamble Absorptive structure having tapered capillaries
US4341207A (en) * 1979-09-07 1982-07-27 Kingsdown Medical Consultants Limited Wound dressing
US4990144A (en) * 1986-08-20 1991-02-05 Smith And Nephew Associated Companies Plc Medicating impressed film wound dressing
US5010883A (en) * 1983-12-24 1991-04-30 Smith & Nephew Associated Companies Plc Surgical dressing
EP0536875A1 (en) * 1991-08-07 1993-04-14 Paul Hartmann Aktiengesellschaft Hydrogel bandage
US5204110A (en) * 1990-05-02 1993-04-20 Ndm Acquisition Corp. High absorbency hydrogel wound dressing
US5423736A (en) * 1992-04-02 1995-06-13 New Dimensions In Medicine, Inc. Wound dressing with dehydrated hydrogel gauze
US5465735A (en) * 1994-12-01 1995-11-14 The Kendall Company Wound dressing
US5501661A (en) * 1993-05-27 1996-03-26 New Dimensions In Medicine, Inc. Method of making a wound dressing product containing a porous layer
US5540922A (en) * 1992-03-30 1996-07-30 Molnlycke Ab Absorbent wound dressing

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929135A (en) * 1974-12-20 1975-12-30 Procter & Gamble Absorptive structure having tapered capillaries
US4341207A (en) * 1979-09-07 1982-07-27 Kingsdown Medical Consultants Limited Wound dressing
US5010883A (en) * 1983-12-24 1991-04-30 Smith & Nephew Associated Companies Plc Surgical dressing
US4990144A (en) * 1986-08-20 1991-02-05 Smith And Nephew Associated Companies Plc Medicating impressed film wound dressing
US5204110A (en) * 1990-05-02 1993-04-20 Ndm Acquisition Corp. High absorbency hydrogel wound dressing
EP0536875A1 (en) * 1991-08-07 1993-04-14 Paul Hartmann Aktiengesellschaft Hydrogel bandage
US5540922A (en) * 1992-03-30 1996-07-30 Molnlycke Ab Absorbent wound dressing
US5423736A (en) * 1992-04-02 1995-06-13 New Dimensions In Medicine, Inc. Wound dressing with dehydrated hydrogel gauze
US5501661A (en) * 1993-05-27 1996-03-26 New Dimensions In Medicine, Inc. Method of making a wound dressing product containing a porous layer
US5465735A (en) * 1994-12-01 1995-11-14 The Kendall Company Wound dressing

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003011352A1 (en) * 2001-07-26 2003-02-13 Johson & Johson Medical Limited Apertured sheet materials consisting of a hydrogel composition
US8058499B2 (en) 2001-11-23 2011-11-15 Systagenix Wound Management (Us), Inc. Absorbent wound dressing containing a hydrogel layer
WO2003045294A1 (en) * 2001-11-23 2003-06-05 Johnson & Johnson Medical Limited Absorbent wound dressing containing a hydrogel layer
GB2382305B (en) * 2001-11-23 2004-12-15 Johnson & Johnson Medical Ltd Absorbent wound dressings containing a hydrogel layer
AU2002365308B2 (en) * 2001-11-23 2007-07-05 Johnson & Johnson Medical Limited Absorbent wound dressing containing a hydrogel layer
US7732655B2 (en) 2001-12-06 2010-06-08 Systagenix Wound Management (Us), Inc. Controlled release therapeutic wound dressings
US7772454B2 (en) 2002-09-27 2010-08-10 Systagenix Wound Management (U.S.), Inc. Wound treatment device
WO2004028423A1 (en) * 2002-09-27 2004-04-08 Johnson & Johnson Medical Limited Wound treatment device
WO2004052414A1 (en) * 2002-12-12 2004-06-24 Johnson & Johnson Medical Limited Absorbent multilayer hydrogel wound dressings
GB2396109B (en) * 2002-12-12 2006-04-19 Johnson & Johnson Medical Ltd Absorbent multilayer hydrogel wound dressings
WO2004112851A1 (en) * 2003-06-23 2004-12-29 Johnson & Johnson Medical Limited Hydrogel compositions comprising enzymes
JP2007517557A (en) * 2004-01-09 2007-07-05 バイオ−ゲイト アーゲーBio−Gate Ag Wound dressing
JP4657222B2 (en) * 2004-01-09 2011-03-23 バイオ−ゲイト アーゲーBio−Gate Ag Wound dressing
JP4809062B2 (en) * 2004-01-30 2011-11-02 久光製薬株式会社 The cover material and the cover material with the adhesive patch
WO2005072669A1 (en) * 2004-01-30 2005-08-11 Hisamitsu Pharmaceutical Co., Inc. Cover material and plaster with cover material
EP1649873A2 (en) * 2004-10-22 2006-04-26 First Water Limited Absorbent materials and articles
EP1649873A3 (en) * 2004-10-22 2007-09-26 First Water Limited Absorbent materials and articles
US8702668B2 (en) 2005-02-17 2014-04-22 The Procter And Gamble Company Sanitary napkins capable of taking complex three-dimensional shape in use
US8211078B2 (en) 2005-02-17 2012-07-03 The Procter And Gamble Company Sanitary napkins capable of taking complex three-dimensional shape in use
US9579238B2 (en) 2005-02-17 2017-02-28 The Procter & Gamble Company Sanitary napkins capable of taking complex three-dimensional shape in use
US8409608B2 (en) 2006-03-10 2013-04-02 Cellulose Concepts, Llc Methods for producing silver-bonded antimicrobial moist wound dressings and moist wound dressings produced by the methods
US8263116B2 (en) 2006-03-10 2012-09-11 Cellulose Concepts, Llc Methods for producing silver-bonded antimicrobial moist wound dressings and moist wound dressings produced by the methods
AU2007238826B2 (en) * 2006-04-11 2012-09-13 Kpr U.S., Llc Wound dressings with anti-microbial and zinc-containing agents
US7799965B2 (en) * 2006-04-11 2010-09-21 Tyco Healthcare Group Lp Wound dressings with anti-microbial and zinc-containing agents
US7750201B2 (en) * 2006-04-11 2010-07-06 Tyco Healthcare Group Lp Wound dressings with anti-microbial and chelating agents
AU2007238818B2 (en) * 2006-04-11 2012-07-05 Kpr U.S., Llc Wound dressings with anti-microbial and chelating agents
RU2445947C2 (en) * 2006-11-07 2012-03-27 Пауль Хартманн Аг Multilayer absorbent wound dressing having wound contact hydrophilic layer
WO2008055586A1 (en) * 2006-11-07 2008-05-15 Paul Hartmann Ag Multi-layer, absorbing wound dressing having a hydrophilic wound contact layer
EP1923077A1 (en) * 2006-11-07 2008-05-21 Paul Hartmann AG Multilayer, absorbent wound dressing with a hydophilic wound contact layer
EP3115033A1 (en) 2008-07-03 2017-01-11 Paul Hartmann AG Wound dressing and method for the production thereof
DE102008031182A1 (en) 2008-07-03 2010-01-07 Paul Hartmann Ag Wound dressing with hydrogel matrix
DE102008031183A1 (en) 2008-07-03 2010-01-07 Paul Hartmann Ag wound dressing
WO2011082772A1 (en) 2009-12-24 2011-07-14 Paul Hartmann Ag Hydrogel matrix having increased absorption capacity for liquids
WO2011095194A1 (en) 2009-12-24 2011-08-11 Paul Hartmann Ag Hydrogel matrix having improved adhesive properties
US9579413B2 (en) 2009-12-24 2017-02-28 Paul Hartmann Ag Hydrogel matrix having improved adhesive properties
US20140255476A1 (en) * 2011-08-19 2014-09-11 University Of Washington Through Its Center For Commercialization Compositions, devices, and methods for treating infections
WO2014130567A1 (en) * 2013-02-20 2014-08-28 Carefusion 2200, Inc. Antimicrobial hydrogel polymers
CN105163768A (en) * 2013-02-20 2015-12-16 开尔弗森2200有限公司 Antimicrobial hydrogel polymers
CN105163768B (en) * 2013-02-20 2018-04-13 开尔弗森2200有限公司 The antimicrobial hydrogel polymer
EP3107619A4 (en) * 2014-02-18 2018-05-02 University Of South Australia Plasma hydrogel therapy

Also Published As

Publication number Publication date
AU1255202A (en) 2002-05-21
GB0027674D0 (en) 2000-12-27
EP1333788A1 (en) 2003-08-13
TW590763B (en) 2004-06-11
JP2004520096A (en) 2004-07-08

Similar Documents

Publication Publication Date Title
EP1263366B1 (en) Textured absorbent article for wound dressing
CA2514078C (en) Wound dressing
RU2615075C2 (en) Wound dressing and methods
AU601471B2 (en) Wound dressing, its preparation and use
EP0630629B1 (en) Hydrogel wound dressing product
ES2348306T3 (en) Multilayer dressing for wounds.
CN101111209B (en) Wound dressing and method for manufacturing the same
CA2028009C (en) Transparent wound dressing
US8672905B2 (en) Wound care article for extraction and control of wound fluids
CA2199357C (en) Spyrosorbent wound dressings for exudate management
US5830496A (en) Wound filler
EP0147119A2 (en) Surgical dressing
US5466231A (en) Laminated sponge device
AU2008259554B2 (en) A wound dressing
AU683684B2 (en) Improved wound dressing
EP0090564B1 (en) Reservoir wound dressing
EP0528091B1 (en) Wound dressing having a roll configuration
JP3810447B2 (en) Wound dressing
US5167613A (en) Composite vented wound dressing
RU2236870C2 (en) Wound bandage
CN102470199B (en) Means for negative pressure wound therapy
EP0968006B1 (en) Dressings
ES2295182T3 (en) A laminate.
JP5053407B2 (en) Wound dressing and wound dressing kit
US5470576A (en) Process for preparing the alginate-containing wound dressing

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2001980764

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2002540687

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2001980764

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001980764

Country of ref document: EP